miDiagnostics
ActiveSummary
The annual accounts of miDiagnostics for fiscal year 2024 show a net loss of 68% of total assets and of 3,276% of the equity at the start of that year. The 2024 annual accounts show equity of €1.99M and a net result of €-18.57M. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 14% of 243 sector peers (fiscal year 2024). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.5% (low).
Checked score
Credit advice for your own amount and term
Signals
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Filed annual accounts As filed with the NBB · 2024 against 2023 · 80 lines
The notes to these accounts (82 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Directors · office · real estate
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Gaston Geenslaan 13001 Leuven2 establishment units
2 parcels
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24038C0158/00C000 | Flanders | 1.5 ha | 1 · 3,050 m² | 8.8 m · 2 fl. |
| 24040B0201/00H002 | Flanders | 7,000 m² | 1 · 1,139 m² | 17.0 m · 4 fl. |
Linked by address, not proof of ownership
Public money · subsidies and aid
Flemish government
2022 to 2025 · 4 entries · 52,778 EUR awarded · 52,778 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 107 EUR | 107 EUR |
| 2024 | 1 | 11,417 EUR | 11,417 EUR |
| 2023 | 1 | 35,024 EUR | 35,024 EUR |
| 2022 | 1 | 6,230 EUR | 6,230 EUR |
Similar companies · same sector, comparable size
Company data · Crossroads Bank
Scores and ratios are computed by Checked and are not a credit decision.